Bausch Health's CEO, Thomas J. Appio, has joined the board of directors of its subsidiary Bausch + Lomb as of August 5, 2026. Alongside Appio, three new directors were appointed, replacing four outgoing members who resigned without disagreements. Bausch Health, holding about 87% of Bausch + Lomb shares, supports these board changes to align with its strategic interests and long-term growth plans for the subsidiary. This move aims to strengthen oversight and drive shareholder value at Bausch + Lomb.
The healthcare chatbots market, valued at $1.02 billion in 2025, is projected to grow to $11.13 billion by 2035 with a CAGR of 27.05%. Growth is fueled by advances in generative AI, virtual healthcare adoption, EHR integration, and clinician shortage...
The glycolic acid market is projected to grow from $377.21 million in 2025 to $818.89 million by 2035, at an 8.06% CAGR. Growth is fueled by rising demand in cosmetics for exfoliation and anti-aging, as well as industrial uses like dyeing and tanning...
DP World has agreed to take over six UK contract logistics sites from GXO, adding over two million square feet of warehouse space and 2,000 employees to its UK operations. These sites serve major grocery retailers like Asda, Sainsbury’s, and the Co-o...
On August 5, 2026, PayPoint Plc announced the vesting of deferred bonus shares granted to its directors and senior managers in July 2023, following continuous employment conditions being met. The shares vested at a price of £6.181815 each, with some ...
BlockComp and Dragonfly have partnered to launch the third annual Crypto Compensation Survey, aiming to create the most comprehensive pay database for the crypto industry. This survey consolidates anonymized compensation data from over 55 crypto firm...
